Clinical Evaluation of a Novel Point-of-Care Assay To Detect Mycoplasma pneumoniae and Associated Macrolide-Resistant Mutations
Toshihiko Kakiuchi, Ippei Miyata, Reiji Kimura, Goh Shimomura, Kunihisa Shimomura, Satoru Yamaguchi, Takato Yokoyama, Kazunobu Ouchi, Muneaki Matsuo
Abstract
= 0.00024). Smart Gene demonstrated excellent utility in the diagnosis of M. pneumoniae and the selection of appropriate antimicrobials for MR mutations at primary medical institutions, which play a central role in community-acquired pneumonia care. The use of this device may reduce referrals to high-level medical institutions for respiratory infections, thereby reducing the medical and economic burdens on patients.
Topics & Concepts
Mycoplasma pneumoniaeConcordancePoint of careGene mutationPneumoniaBiologyMacrolide AntibioticsPoint mutationAntibioticsInternal medicineVirologyMedicineGeneMutationMicrobiologyErythromycinPathologyGeneticsPneumonia and Respiratory InfectionsMicrobial infections and disease researchRespiratory viral infections research